Skip to content

in Our Study we Compare Results of Two Oncoplastic Breast Surgery (Short Scar Reduction Mammoplasty and Wise Pattern Reduction Mammoplasty) as Surgical Treatment of Breast Cancer

Evaluation of Short Scar Periareolar Inferior Pedicle Reduction Mammoplasty in Oncoplastic Breast Surgery

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06901180
Enrollment
60
Registered
2025-03-28
Start date
2025-04-01
Completion date
2026-08-01
Last updated
2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of Short Scar Periareolar Inferior Pedicle Reduction Mammoplasty in Oncoplastic Breast Surgery

Brief summary

in our study we compare results of two oncoplastic breast surgery (short scar reduction mammoplasty and wise pattern reduction mammoplasty) as surgical treatment of breast cancer

Interventions

PROCEDUREshort scar periareolar inferior pedicle reduction mammoplasty

reduction mammoplasty that minimizes scar with better cosmetic outcomes

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Female patients with ages ranging from 25 to 75 years. 2. Patients with operable breast cancer (Stage I, II and IIIa). 3. Patients with moderate to large /ptotic breasts.

Exclusion criteria

1. Patients with a contraindication to breast conservative surgery: 1. Multi-centric disease that can't be incorporated by local excision through a single incision that achieves adequate safety margin and satisfactory cosmetic results. 2. inflammatory carcinoma. 3. Contraindications to postoperative radiation e.g. pregnancy, pre-existing lung disease with reduced diffusing capacity and pulmonary TB. 4. diffuse suspicious malignant micro-calcification on mammography. 5. inability to attain negative surgical margins. 6. cardiomyopathy 7. connective tissue disorders with significant vasculitis. 2. Previous chest wall or breast radiation. 3. Patients' refusal participation.

Design outcomes

Primary

MeasureTime frameDescription
oncological outcomes1 yeardetect incidence of local recurrence of malignancy
post operative complications1 monthsurgical complications
cosmetic outcomes1 yearpatients' satisfaction with their breast

Countries

Egypt

Contacts

Primary Contactahmed gadelkarim, ms
ahmedgadalkreem@gmail.com01121280177

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026